N-Carbethoxy-3-methoxy-4-piperidone, 97.0%, 1g

(1-(Tert-butoxycarbonyl)-1H-indol-5-yl)boronic acid, 97%, 250mg

1,4-BIS(DIPHENYLAMINO)BENZENE, 95%, 1g

Colonna capillare per GC ROTI®Cap-1701 MS, 30 m, 0,32 mm, 0,25 µm, 1 Pezzo(i)

4-Bromo-3-trifluoromethylphenol, 97.0%, 25g

2,5-Dioxopyrrolidin-1-yl 2-(acetylthio)acetate, 95.0%, 100mg

5-BROMO-6-FLUORO-3-IODO-1H-INDAZOLE, 97%, 100mg

D-Glutamine, N2-[(phenylmethoxy)carbonyl]-N-(triphenylmethyl)-, 97%, 1g

1,2-Bis(4-fluorophenyl)disulfane>98.0%(GC)5g

1-((2R,3R,4S,5S)-3,5-DIFLUORO-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)PYRIMIDINE-2,4(1H,3H)-DIONE, 90.0%, 500mg

ethyl 5-(4-isopropylphenyl)-5-oxovalerate, 97.0%, 1g

4-{2,2-Bis[(4-formylphenoxy)methyl]-3-(4-formylphenoxy)propoxy}benzaldehyde, 97%, 250mg

4-(3-(3,5-Dichlorophenyl)-4,4,4-trifluoro-3-hydroxybutanoyl)-2-methylbenzoic acid, 98%, 5g